Effect of tiotropium on spontaneous expiratory flow-volume curves during exercise in GOLD 1&2 COPD

J. Porszasz, S. Ma, R. Cao, A. Gore, W. Phillips, R. Cooper, F. Maltais, G. T. Ferguson, D. E. O'Donnell, H. Paden, R. Casaburi (Torrance, Urbana, Livonia, Ridgefield, United States Of America; Québec, Kingston, Canada)

Source: Annual Congress 2013 –Clinical trials of LAMAs, LABAs, MABAs and theophylline for asthma and COPD
Session: Clinical trials of LAMAs, LABAs, MABAs and theophylline for asthma and COPD
Session type: Thematic Poster Session
Number: 751
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Porszasz, S. Ma, R. Cao, A. Gore, W. Phillips, R. Cooper, F. Maltais, G. T. Ferguson, D. E. O'Donnell, H. Paden, R. Casaburi (Torrance, Urbana, Livonia, Ridgefield, United States Of America; Québec, Kingston, Canada). Effect of tiotropium on spontaneous expiratory flow-volume curves during exercise in GOLD 1&2 COPD. Eur Respir J 2013; 42: Suppl. 57, 751

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Effects of nasal positive expiratory pressure on dynamic hyperinflation during exercise in patients with COPD
Source: Annual Congress 2013 –Various issues in clinical respiratory physiology
Year: 2013

Positive expiratory pressure therapy improves inspiratory capacity and physical activity in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2013 –The best posters in exercise testing and physical inactivity
Year: 2013


Respiratory timing and dynamic hyperinflation during incremental exercise in patients with COPD
Source: International Congress 2016 – Unmasking the mechanisms of symptoms and exercise limitation in disease
Year: 2016

Dyspnea, inspiratory and expiratory muscles in mild and severe COPD compared to healthy individuals
Source: International Congress 2016 – Pathophysiological mechanisms at different levels: lung, airways, muscles and symptom perception
Year: 2016


Effects of inhaled furosemide on exercise capacity and on dyspnea in patients with COPD
Source: International Congress 2015 – Novel treatments for cough, asthma, COPD and bronchiectasis
Year: 2015

The effect of tiotropium on exacerbations and airflow in patients with COPD
Source: Eur Respir J 2006; 27: 547-555
Year: 2006



Effect of salmeterol on the ventilatory response to exercise in chronic obstructive pulmonary disease
Source: Eur Respir J 2004; 24: 86-94
Year: 2004



Usefulness of post bronchodilator FVC in the evaluation and spirometric evolution of COPD patients
Source: Annual Congress 2013 –Monitoring lung function in airway diseases
Year: 2013


Treatment with corticosteroids and yearly decline of forced expiratory flow (FEV1) in patients with severe chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2008 - Respiratory structure and function
Year: 2008


Inspiratory fraction and exercise impairment in COPD patients GOLD stages II-III
Source: Eur Respir J 2006; 28: 939-944
Year: 2006



First dose response to tiotropium in COPD: Impact on dyspnea, lung hyperinflation and distal airways
Source: Annual Congress 2013 –COPD drugs: new findings
Year: 2013


Does dynamic hyperinflation contribute to dyspnoea during exercise in patients with COPD?
Source: Eur Respir J 2012; 40: 322-329
Year: 2012



Exercise and dyspnoea in COPD
Source: Eur Respir Rev 2006; 15: 72-79
Year: 2006



Exercise capacity and lobar hyperinflation in patients with COPD
Source: Annual Congress 2013 –The latest insights in exercise testing and physical inactivity
Year: 2013


Positive expiratory pressure breathing accelerates recovery of exertional dyspnea in participants with COPD: A randomised cross over trial
Source: International Congress 2016 – Pathophysiological mechanisms at different levels: lung, airways, muscles and symptom perception
Year: 2016


Acute effects of expiratory positive airway pressure on exercise capacity in patients with COPD
Source: International Congress 2017 – Novel treatments for rehabilitation of patients with chronic respiratory diseases
Year: 2017

Effect of umeclidinium/vilanterol (UMEC/VI) on inspiratory capacity/total lung capacity ratio in hyperinflated COPD patients
Source: International Congress 2015 – New data on established treatments for COPD
Year: 2015


Dynamic hyperinflation impairs cardiac performance during maximal exercise test in COPD
Source: International Congress 2015 – Dyspnoea and respiratory muscle mechanics dysfunction in disease
Year: 2015


Effect of tiotropium compared to salmetrol on dynamic hyperinflation in patients with chronic obstructive pulmonary disease
Source: International Congress 2016 – Novel avenues in the treatment of COPD I
Year: 2016

Effects of expiratory positive airway pressure on exercise dynamic hyperinflation in COPD patients
Source: Annual Congress 2010 - Noninvasive ventilation: technical, logistical and organisational aspects
Year: 2010